Zobrazeno 1 - 10
of 2 947
pro vyhledávání: '"Hughes R"'
Autor:
Fischer K; Department of Biochemistry, University of Cambridge, Cambridge, UK., Lulla A; Department of Biochemistry, University of Cambridge, Cambridge, UK., So TY; MRC Toxicology Unit, Gleeson Building, Cambridge, UK., Pereyra-Gerber P; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Raybould MIJ; Oxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford, UK., Kohler TN; Department of Biochemistry, University of Cambridge, Cambridge, UK., Yam-Puc JC; MRC Toxicology Unit, Gleeson Building, Cambridge, UK., Kaminski TS; Department of Biochemistry, University of Cambridge, Cambridge, UK.; Department of Molecular Biology, Institute of Biochemistry, Faculty of Biology, University of Warsaw, Warsaw, Poland., Hughes R; MRC Toxicology Unit, Gleeson Building, Cambridge, UK., Pyeatt GL; Department of Biochemistry, University of Cambridge, Cambridge, UK., Leiss-Maier F; Department of Biochemistry, University of Cambridge, Cambridge, UK., Brear P; Department of Biochemistry, University of Cambridge, Cambridge, UK., Matheson NJ; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK.; NHS Blood and Transplant, Cambridge, UK., Deane CM; Oxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford, UK., Hyvönen M; Department of Biochemistry, University of Cambridge, Cambridge, UK., Thaventhiran JED; MRC Toxicology Unit, Gleeson Building, Cambridge, UK. jedt2@mrc-tox.cam.ac.uk., Hollfelder F; Department of Biochemistry, University of Cambridge, Cambridge, UK. fh111@cam.ac.uk.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.
Autor:
Brandtmüller A; MSD, Budapest, Hungary; Pedro Miguel Gonzalez Capote, Can Misses Hospital, Eivissa, Spain., Meiwald A; Adelphi Values PROVE™, Bollington, UK; Pedro Miguel Gonzalez Capote, Can Misses Hospital, Eivissa, Spain. Electronic address: anne.meiwald@adelphivalues.com., Oliver E; Adelphi Values PROVE™, Bollington, UK; Pedro Miguel Gonzalez Capote, Can Misses Hospital, Eivissa, Spain., Hughes R; Adelphi Values PROVE™, Bollington, UK; Pedro Miguel Gonzalez Capote, Can Misses Hospital, Eivissa, Spain., Capote PMG; Adelphi Values PROVE™, Bollington, UK; Pedro Miguel Gonzalez Capote, Can Misses Hospital, Eivissa, Spain., Weston G; Adelphi Values PROVE™, Bollington, UK; Pedro Miguel Gonzalez Capote, Can Misses Hospital, Eivissa, Spain., Benčina G; Pedro Miguel Gonzalez Capote, Can Misses Hospital, Eivissa, Spain; Center for Observational and Real-World Evidence, MSD Spain, Madrid.
Publikováno v:
Journal of cancer policy [J Cancer Policy] 2024 Aug 13, pp. 100499. Date of Electronic Publication: 2024 Aug 13.
Autor:
Cowan KJ; Merck KGaA, Research & Development, Drug Metabolism & Pharmacokinetics New Biological Entities, 64293Darmstadt, Germany., Kunz U; Boehringer Ingelheim Pharma GmbH & Co. KG, Translational Medicine & Clinical Pharmacology, 88400Biberach an der Riss, Germany., Blattmann P; Idorsia Pharmaceuticals Ltd, Translational Sciences, 4123Allschwil, Switzerland., Gulati P; F. Hoffmann La Roche Ltd Bioanalysis & Biomarkers Chapter, Pharmaceutical Sciences, 4070Basel, Switzerland., Hughes R; Resolian Bioanalytics, Newmarket Road, Fordham, CB7 5WW, United Kingdom., Andersen L; Novo Nordisk A/S, Clinical LCMS Bioanalysis, DK-2760, Maaløv, Denmark., Goodman J; Bioanalytical Services, Celerion, Lincoln, NE 68502, USA., Lambert F; Charles River Laboratories, Immunology, Bioanalysis & Biomarkers, EH33 2NE, Edinburgh, United Kingdom., Lawrence J; Invox Pharma, Translational Sciences, CB21 6AD, Cambridge, United Kingdom., Thwaites D; LabCorp Drug Development, LabCorp Drug Development, Immunology & Immunotoxicology, HG3 1PY, Harrogate, United Kingdom., Golob M; Nuvisan GmbH, Bioanalysis, 89231, Neu-Ulm, Germany., Nelson R; BioAgilytix Laboratories, 22339Hamburg, Germany., Timmerman P; European Bioanalysis Forum vzw (EBF), Havenlaan 86c b204, 1000Brussels, Belgium.
Publikováno v:
Bioanalysis [Bioanalysis] 2024 Aug 05, pp. 1-8. Date of Electronic Publication: 2024 Aug 05.
Autor:
As-Sanie S; Department of Obstetrics and Gynecology, University of Michigan (Dr. As-Sanie), Ann Arbor, Michigan. Electronic address: sassanie@med.umich.edu., Shafrir AL; Division of Adolescent and Young Adult Medicine, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School (Dr. Shafrir), Boston, Massachusetts; Department of Nutrition and Public Health, School of Nursing and Health Sciences, Merrimack College (Dr. Shafrir), North Andover, Massachusetts; Department of Nutrition and Public Health, School of Nursing and Health Sciences, Merrimack College (Dr. Shafrir), North Andover, MA., Halvorson L; Bayer US Pharmaceuticals (Dr. Halvorson), Whippany, New Jersey., Chawla R; AccuScript Consultancy (Dr. Chawla), Ludhiana, Punjab, India., Hughes R; AccuScript Consultancy (Dr. Hughes), Reading, UK., Merz M; Bayer Pharma AG (Dr. Merz), Berlin, Germany.
Publikováno v:
Journal of minimally invasive gynecology [J Minim Invasive Gynecol] 2024 Aug; Vol. 31 (8), pp. 653-666.e5. Date of Electronic Publication: 2024 May 09.
Autor:
Lillo P; Departamento de Neurología Sur, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Geroscience Center for Brain Health and Metabolism (GERO), Santiago, Chile.; Unidad de Neurología, Hospital San José, SSMN, Santiago, Chile., Zitko P; Departamento de Salud Global, Escuela de Salud Pública, Universidad de Chile, Santiago, Chile., Godoy-Reyes G; Departamento de Neurología Sur, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Servicio de Neurología, Complejo Asistencial Barros Luco, Servicio de Salud Metropolitano Sur, Santiago, Chile., Asenjo G; Escuela de Salud Pública, Facultad de Medicina, Universidad de Chile, Santiago, Chile., Sáez D; Departamento de Neurología Sur, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Servicio de Neurología, Complejo Asistencial Barros Luco, Servicio de Salud Metropolitano Sur, Santiago, Chile., Cea G; Departamento de Neurología Sur, Facultad de Medicina, Universidad de Chile, Santiago, Chile., Navarrete P; Departamento de Neurología Sur, Facultad de Medicina, Universidad de Chile, Santiago, Chile., Valenzuela D; Departamento de Neurología Sur, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Servicio de Neurología, Complejo Asistencial Barros Luco, Servicio de Salud Metropolitano Sur, Santiago, Chile., Hughes R; Unidad de Neurología, Hospital San José, SSMN, Santiago, Chile.; Servicio de Neurología, Hospital Clínico Universidad de Chile, Santiago, Chile., Heverin M; Academic Unit of Neurology, Clinical Medicine, Trinity College Dublin, Dublin, Ireland, and., Logroscino G; Center for Neurodegenerative Diseases and the Aging Brain. Fondazione 'Card. G. Panico' Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari 'Aldo Moro', Bari, Italy., Hardiman O; Academic Unit of Neurology, Clinical Medicine, Trinity College Dublin, Dublin, Ireland, and.
Publikováno v:
Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2024 Aug; Vol. 25 (5-6), pp. 528-532. Date of Electronic Publication: 2024 Mar 20.
Autor:
Hoskin P; Mount Vernon Cancer Centre, Northwood, Middlesex HA6 2RN, UK. Electronic address: peterhoskin@nhs.net., Rojas A; Mount Vernon Cancer Centre, Northwood, Middlesex HA6 2RN, UK., Ostler P; Mount Vernon Cancer Centre, Northwood, Middlesex HA6 2RN, UK., Hughes R; Mount Vernon Cancer Centre, Northwood, Middlesex HA6 2RN, UK., Alonzi R; Mount Vernon Cancer Centre, Northwood, Middlesex HA6 2RN, UK., Lowe G; Mount Vernon Cancer Centre, Northwood, Middlesex HA6 2RN, UK.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jul 10; Vol. 199, pp. 110426. Date of Electronic Publication: 2024 Jul 10.
Autor:
Wilford T; Resolian, Fordham, Cambridgeshire CB7 5WW, United Kingdom of Great Britain & Northern Ireland., Bartlett PD; Crescendo Biologics Limited, Cambridge CB22 3AT, United Kingdom of Great Britain & Northern Ireland., Schlag A; Crescendo Biologics Limited, Cambridge CB22 3AT, United Kingdom of Great Britain & Northern Ireland., Jasaitis L; Crescendo Biologics Limited, Cambridge CB22 3AT, United Kingdom of Great Britain & Northern Ireland., Pandha H; University of Surrey, School of Biosciences, Guildford GU2 7XH, Surrey, United Kingdom of Great Britain & Northern Ireland., Pierce AJ; Crescendo Biologics Limited, Cambridge CB22 3AT, United Kingdom of Great Britain & Northern Ireland., Hughes R; Resolian, Fordham, Cambridgeshire CB7 5WW, United Kingdom of Great Britain & Northern Ireland.
Publikováno v:
Bioanalysis [Bioanalysis] 2024 Jul 03, pp. 1-13. Date of Electronic Publication: 2024 Jul 03.
Autor:
Hughes R 4th; Richard Hughes IV (rhughesiv@law.gwu.edu) is a partner with Epstein Becker Green in Washington, D.C., and a professorial lecturer in law at the George Washington University Law School, also in Washington, D.C. The views reflected here are his own. To access the authors' disclosures, click on the Details tab of the article online.
Publikováno v:
Health affairs (Project Hope) [Health Aff (Millwood)] 2024 Jul; Vol. 43 (7), pp. 1047-1051.
Autor:
Long MB; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., Gilmour A; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., Kehl M; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Tabor DE; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Keller AE; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Warrener P; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Gopalakrishnan V; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Rosengren S; Translational Science and Experimental Medicine, Respiratory & Immunology, Respiratory and Immunology, and., Crichton ML; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., McIntosh E; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., Giam YH; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., Keir HR; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., Brailsford W; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and., Hughes R; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Belvisi MG; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and., Sellman BR; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., DiGiandomenico A; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Chalmers JD; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 Jul 01; Vol. 210 (1), pp. 35-46.
Autor:
Padgett CH; Department of Pharmacy, Saint Joseph Hospital, Lexington, KY, USA., King GS; Department of Pharmacy, Saint Joseph Hospital, Lexington, KY, USA., Hughes RE; Department of Pharmacy, Saint Joseph Hospital, Lexington, KY, USA., Hull MN; Department of Pharmacy, Saint Joseph Hospital, Lexington, KY, USA., Colon EA; Department of Critical Care/Pulmonology, Saint Joseph Hospital, Lexington, KY, USA.
Publikováno v:
Journal of pharmacy practice [J Pharm Pract] 2024 Jun 14, pp. 8971900241262359. Date of Electronic Publication: 2024 Jun 14.